| Cvs Pharmacy #03344 | |
| 4050 Dean Lakes Blvd, Shakopee, Minnesota 55379 | |
| (952) 402-9039 |
| Name | Cvs Pharmacy #03344 |
|---|---|
| Organization Name | Grand St Paul Cvs Llc |
| Location | 4050 Dean Lakes Blvd, Shakopee, Minnesota 55379 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (952) 402-9039 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a guest post on the GlobalPost's "Global Pulse" blog, Janet Fleischman, a senior associate at the CSIS Global Health Policy Center, describes the Malawian government's "plans to launch a 'test and treat' program in which all HIV-infected pregnant women will immediately be put on antiretroviral treatment drugs for life."
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced today that it has sold its royalty interest in CIMZIA® (certolizumab pegol) marketed by UCB S.A. for $4 million to an undisclosed buyer. The manufacture of CIMZIA is covered by a license to XOMA's Bacterial Cell Expression technology.
With the current drug discovery paradigm, it takes up to 15 years to translate an idea, such as hypothesizing a certain protein is important in a disease and testing this with targeting the protein with a drug, all the way through to proof of concept...
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a $10.6 million grant to researchers at the Virginia Bioinformatics Institute (VBI) and collaborators to determine how the human immune system responds to infection by pathogens of the gut. The funding will be used to apply mathematical modeling to the study of immune responses to gut pathogens.
› Verified 7 days ago
| NPI Number | 1710005830 |
| Organization Name | GRAND ST PAUL CVS LLC |
| Doing Business As | CVS PHARMACY # 03344 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4050 Dean Lake Blvd, Shakopee, MN 55379 |
| Phone Number | 952-402-9039 |
News Archive
In a guest post on the GlobalPost's "Global Pulse" blog, Janet Fleischman, a senior associate at the CSIS Global Health Policy Center, describes the Malawian government's "plans to launch a 'test and treat' program in which all HIV-infected pregnant women will immediately be put on antiretroviral treatment drugs for life."
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced today that it has sold its royalty interest in CIMZIA® (certolizumab pegol) marketed by UCB S.A. for $4 million to an undisclosed buyer. The manufacture of CIMZIA is covered by a license to XOMA's Bacterial Cell Expression technology.
With the current drug discovery paradigm, it takes up to 15 years to translate an idea, such as hypothesizing a certain protein is important in a disease and testing this with targeting the protein with a drug, all the way through to proof of concept...
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a $10.6 million grant to researchers at the Virginia Bioinformatics Institute (VBI) and collaborators to determine how the human immune system responds to infection by pathogens of the gut. The funding will be used to apply mathematical modeling to the study of immune responses to gut pathogens.
› Verified 7 days ago
News Archive
In a guest post on the GlobalPost's "Global Pulse" blog, Janet Fleischman, a senior associate at the CSIS Global Health Policy Center, describes the Malawian government's "plans to launch a 'test and treat' program in which all HIV-infected pregnant women will immediately be put on antiretroviral treatment drugs for life."
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced today that it has sold its royalty interest in CIMZIA® (certolizumab pegol) marketed by UCB S.A. for $4 million to an undisclosed buyer. The manufacture of CIMZIA is covered by a license to XOMA's Bacterial Cell Expression technology.
With the current drug discovery paradigm, it takes up to 15 years to translate an idea, such as hypothesizing a certain protein is important in a disease and testing this with targeting the protein with a drug, all the way through to proof of concept...
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a $10.6 million grant to researchers at the Virginia Bioinformatics Institute (VBI) and collaborators to determine how the human immune system responds to infection by pathogens of the gut. The funding will be used to apply mathematical modeling to the study of immune responses to gut pathogens.
› Verified 7 days ago
Cvs Pharmacy #03344 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4050 Dean Lakes Blvd, Shakopee, Minnesota 55379 Phone: (952) 402-9039 | |
Cvs Pharmacy #16619 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1685 17th Ave E, Shakopee, Minnesota 55379 Phone: (952) 445-1727 | |
Hy-vee Pharmacy (1562) Type: Community/Retail Pharmacy Location: 1451 Adams St S, Shakopee, Minnesota 55379 Phone: (952) 403-1522 | |
Park Nicollet Health Care Products Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1455 Saint Francis Ave, Shakopee, Minnesota 55379 Phone: (952) 993-7644 | |
Park Nicollet Health Care Products Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1601 Saint Francis Ave, Shakopee, Minnesota 55379 Phone: (952) 993-7750 |